These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 8182219)
1. Biochemical analyses of macromolecular matrix components in patients with pseudoxanthoma elasticum. Sakuraoka K; Tajima S; Nishikawa T; Seyama Y J Dermatol; 1994 Feb; 21(2):98-101. PubMed ID: 8182219 [TBL] [Abstract][Full Text] [Related]
2. Immunochemical identification of abnormal constituents in the dermis of pseudoxanthoma elasticum patients. Baccarani-Contri M; Vincenzi D; Cicchetti F; Mori G; Pasquali-Ronchetti I Eur J Histochem; 1994; 38(2):111-23. PubMed ID: 7524808 [TBL] [Abstract][Full Text] [Related]
3. Elastase digestion of normal and pseudoxanthoma elasticum lesional skin elastins. Schwartz E; Thieberg M; Cruickshank FA; Lebwohl M Exp Mol Pathol; 1991 Oct; 55(2):190-5. PubMed ID: 1936214 [TBL] [Abstract][Full Text] [Related]
5. Structural characterization of the skin glycosaminoglycans in patients with pseudoxanthoma elasticum. Maccari F; Volpi N Int J Dermatol; 2008 Oct; 47(10):1024-7. PubMed ID: 18986348 [TBL] [Abstract][Full Text] [Related]
6. Pseudoxanthoma elasticum (PXE): ultrastructural and biochemical study on proteoglycan and proteoglycan-associated material produced by skin fibroblasts in vitro. Tiozzo Costa R; Baccarani Contri M; Cingi MR; Pasquali Ronchetti I; Salvini R; Rindi S; De Luca G Coll Relat Res; 1988 Jan; 8(1):49-64. PubMed ID: 3345648 [TBL] [Abstract][Full Text] [Related]
7. The mineralization of elastic fibers and alterations of extracellular matrix in pseudoxanthoma elasticum. Ultrastructure, immunocytochemistry, and X-ray analysis. Walker ER; Frederickson RG; Mayes MD Arch Dermatol; 1989 Jan; 125(1):70-6. PubMed ID: 2910208 [TBL] [Abstract][Full Text] [Related]
8. Pseudoxanthoma elasticum. Biochemical and ultrastructural studies. Pasquali-Ronchetti I; Volpin D; Baccarani-Contri M; Castellani I; Peserico A Dermatologica; 1981; 163(4):307-25. PubMed ID: 7308552 [TBL] [Abstract][Full Text] [Related]
9. Fibrillin immunofluorescence in pseudoxanthoma elasticum. Godfrey M; Cisler J; Geerts ML; Christiano A; Uitto J; De Bie S; DePaepe A J Am Acad Dermatol; 1995 Apr; 32(4):589-94. PubMed ID: 7896947 [TBL] [Abstract][Full Text] [Related]
10. Nonlinear optical microscopy is a novel tool for the analysis of cutaneous alterations in pseudoxanthoma elasticum. Kiss N; Fésűs L; Bozsányi S; Szeri F; Van Gils M; Szabó V; Nagy AI; Hidvégi B; Szipőcs R; Martin L; Vanakker O; Arányi T; Merkely B; Wikonkál NM; Medvecz M Lasers Med Sci; 2020 Oct; 35(8):1821-1830. PubMed ID: 32372237 [TBL] [Abstract][Full Text] [Related]
11. Proteoglycan alterations in skin fibroblast cultures from patients affected with pseudoxanthoma elasticum. Passi A; Albertini R; Baccarani Contri M; de Luca G; de Paepe A; Pallavicini G; Pasquali Ronchetti I; Tiozzo R Cell Biochem Funct; 1996 Jun; 14(2):111-20. PubMed ID: 8640951 [TBL] [Abstract][Full Text] [Related]
12. Abnormalities of connective tissue components in lesional and non-lesional tissue of patients with pseudoxanthoma elasticum. Lebwohl M; Schwartz E; Lemlich G; Lovelace O; Shaikh-Bahai F; Fleischmajer R Arch Dermatol Res; 1993; 285(3):121-6. PubMed ID: 8503691 [TBL] [Abstract][Full Text] [Related]